Tech Company Financing Transactions
CoLucid Pharmaceuticals Funding Round
CoLucid Pharmaceuticals closed a $2 million financing round on 3/3/2011. Investors included private investors.
Transaction Overview
Company Name
Announced On
3/3/2011
Transaction Type
Debt
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
P.O. Box 425227
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
CoLucid Pharma is a biotech company focusing on therapies for CNS disorders, Migraine, sleep/wake disorders, chronic pain, Alzheimers, and psychiatric disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Mathers
Chief Financial Officer
Matthew Dallas
VP - Bus. Development
Linda Hogan
VP - General Counsel
Daniel Boeglin
VP - R & D
Nadia Rupniak
VP - Regulatory Affairs
Bernice Kuca
Browse more venture capital transactions:
Prev: 3/3/2011: Rapid7 venture capital transaction
Next: 3/3/2011: Reval venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs